Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms

Stem Cells

Volumn 30, Issue 10, 2012, Pages 2076-2087

  Ibrahim, Elsayed E ^a,b,c   Babaei Jadidi, Roya ^a,b   Saadeddin, Anas ^a,b   Spencer Dene, Bradley ^d   Hossaini, Sina ^a,b   Abuzinadah, Mohammed ^a,b   Li, Ningning ^a,b   Fadhil, Wakkas ^a   Ilyas, Mohammad ^d   Bonnet, Dominique ^a   Nateri, Abdolrahman S ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c Mansoura University   (Egypt)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cancer stem cell; NANOG1 catenin c JUN

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR NANOG; WNT PROTEIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CELL DENSITY; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CLONOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; EMBRYONIC STEM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; XENOGRAFT;

ADAPTOR PROTEIN COMPLEX 1; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; BINDING SITES; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PSEUDOGENES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; WNT PROTEINS;

MURINAE;

EID: 84866702740     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1182     Document Type: Article

References (58)

1. Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007;19:150-158.
2. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005;434:843-850.
3. Reya T, Duncan AW, Ailles L et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003;423:409-414.
4. Vermeulen L, De Sousa EMF, van der Heijden M et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010;12:468-476.
5. Barker N, Ridgway RA, van Es JH et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009;457:608-611.
6. 2 regulates stem cells through Wnt/beta-catenin signalling. Nat Cell Biol 2010;12:1007-1013.
7. Chambers I, Colby D, Robertson M et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003;113:643-655.
8. Pan G, Thomson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 2007;17:42-49.
9. Booth HA, Holland PW. Eleven daughters of NANOG. Genomics 2004;84:229-238.
10. Eberle I, Pless B, Braun M et al. Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells. Nucleic Acids Res 2010;38:5384-5395.
11. Hart AH, Hartley L, Parker K et al. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 2005;104:2092-2098.
12. Ishiguro T, Sato A, Ohata H et al. Differential expression of nanog1 and nanogp8 in colon cancer cells. Biochem Biophys Res Commun 2012;418:199-204.
13. Ezeh UI, Turek PJ, Reijo RA et al. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005;104:2255-2265.
14. Jeter CR, Badeaux M, Choy G et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009;27:993-1005.
15. Saiki Y, Ishimaru S, Mimori K et al. Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells. Ann Surg Oncol 2009;16:2638-2644.
16. Zbinden M, Duquet A, Lorente-Trigos A et al. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J 2010;29:2659-2674.
17. Zhang J, Wang X, Li M et al. NANOGP8 is a retrogene expressed in cancers. FEBS J 2006;273:1723-1730.
18. Sridharan R, Tchieu J, Mason MJ et al. Role of the murine reprogramming factors in the induction of pluripotency. Cell 2009;136:364-377.
19. Po A, Ferretti E, Miele E et al. Hedgehog controls neural stem cells through p53-independent regulation of Nanog. EMBO J 2010;29:2646-2658.
20. Takao Y, Yokota T, Koide H. Beta-catenin up-regulates Nanog expression through interaction with Oct-3/4 in embryonic stem cells. Biochem Biophys Res Commun 2007;353:699-705.
21. Xu RH, Sampsell-Barron TL, Gu F et al. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 2008;3:196-206.
22. Varnat F, Siegl-Cachedenier I, Malerba M et al. Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas. EMBO Mol Med 2010;2:440-457.
23. Meng HM, Zheng P, Wang XY et al. Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer. Cancer Biol Ther 2010;9:295-302.
24. Ben-Porath I, Thomson MW, Carey VJ et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008;40:499-507.
25. Wong DJ, Liu H, Ridky TW et al. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008;2:333-344.
26. Kuroda T, Tada M, Kubota H et al. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 2005;25:2475-2485.
27. Rodda DJ, Chew JL, Lim LH et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 2005;280:24731-24737.
28. Kim CG, Chung IY, Lim Y et al. A Tcf/Lef element within the enhancer region of the human NANOG gene plays a role in promoter activation. Biochem Biophys Res Commun 2011;410:637-642.
29. Pereira L, Yi F, Merrill BJ. Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. Mol Cell Biol 2006;26:7479-7491.
30. Wu da Y, Yao Z. Isolation and characterization of the murine Nanog gene promoter. Cell Res 2005;15:317-324.
31. Mann B, Gelos M, Siedow A et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999;96:1603-1608.
32. Nateri AS, Spencer-Dene B, Behrens A. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 2005;437:281-285.
33. Nelson JD, Denisenko O, Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc 2006;1:179-185.
34. Anneren C, Cowan CA, Melton DA. The Src family of tyrosine kinases is important for embryonic stem cell self-renewal. J Biol Chem 2004;279:31590- 31598.
35. Hyslop L, Stojkovic M, Armstrong L et al. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 2005;23:1035-1043.
36. Kielman MF, Rindapaa M, Gaspar C et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet 2002;32:594-605.
37. Martin GR. Teratocarcinomas and mammalian embryogenesis. Science 1980;209:768-776.
38. Doble BW, Patel S, Wood GA et al. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell 2007;12:957-971.
39. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 2008;8:545-554.
40. Rhee I, Bachman KE, Park BH et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002;416:552-556.
41. Dick E, Matsa E, Bispham J et al. Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines. Stem Cell Res 2011;6:158-167.
42. Miyoshi N, Ishii H, Nagai K et al. Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci USA 2010;107:40-45.
43. Eisenberg LM, Janne OA. Nucleotide sequence of the 5′-flanking region of the murine ornithine decarboxylase gene. Nucleic Acids Res 1989;17:2359.
44. Valerio D, Duyvesteyn MG, Dekker BM et al. Adenosine deaminase: Characterization and expression of a gene with a remarkable promoter. EMBO J 1985;4:437-443.
45. Walsh MJ, Tsao KL, LeLeiko NS. Characterization of DNA-protein interactions within a distal regulatory element upstream of a mammalian housekeeping gene promoter. J Biol Chem 1992;267:7026-7035.
46. Tan SM, Wang ST, Hentze H et al. A UTF1-based selection system for stable homogeneously pluripotent human embryonic stem cell cultures. Nucleic Acids Res 2007;35:e118.
47. Akiyoshi T, Nakamura M, Koga K et al. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation. Gut 2006;55:991-999.
48. He J, Sheng T, Stelter AA et al. Suppressing Wnt signaling by the hedgehog pathway through sFRP-1. J Biol Chem 2006;281:35598-35602.
49. Varnat F, Duquet A, Malerba M et al. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 2009;1:338-351.
50. Nateri AS, Riera-Sans L, Da Costa C et al. The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 2004;303:1374-1378.
51. Saadeddin A, Babaei-Jadidi R, Spencer-Dene B et al. The links between transcription, beta-catenin/JNK signaling, and carcinogenesis. Mol Cancer Res 2009;7:1189-1196.
52. Gazouli M, Roubelakis MG, Theodoropoulos GE et al. OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer. Mol Carcinog 2012;51:165-173.
53. Karoubi G, Cortes-Dericks L, Gugger M et al. Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma. J Surg Oncol 2010;102:689-698.
54. Ito K, Bernardi R, Morotti A et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 2008;453:1072-1078.
55. Moore N, Lyle S. Quiescent, slow-cycling stem cell populations in cancer: A review of the evidence and discussion of significance. J Oncol 2011; 2011. pii: 396076.
56. Katoh M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 2007;3:30-38.
57. Kwon C, Cheng P, King IN et al. Notch post-translationally regulates beta-catenin protein in stem and progenitor cells. Nat Cell Biol 2011;13:1244-1251.
58. Jeter CR, Liu B, Liu X et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 2011;30:3833-3845.